arrow
L

Lara Dunn

Memorial Sloan Kettering Cancer Center
H指数:34
被引数:5,883

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinoma

定义鼻窦鳞状细胞癌新辅助全身治疗后反应适应性手术

2026-02-010
PRE
The Use of Protons in the Management of Recurrent, Previously Irradiated Adenoid Cystic Carcinoma

质子治疗在复发、既往接受过放射治疗的腺样囊性癌管理中的应用

2026-01-010
OAAI
Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case–control study

调强质子治疗与调强放射治疗在鼻咽癌中的比较:一项病例对照研究

2025-12-290
OAAI
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC

对局部晚期HNSCC应用新辅助西妥昔单抗、铂类药物和紫杉类药物的病理学反应

2025-10-170
PRE
Prospective Trial Evaluating Post-operative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-related Oropharyngeal Carcinoma (PATH study)

前瞻性试验评估基于术后人乳头瘤病毒循环肿瘤DNA指导的辅助治疗对与人乳头瘤病毒相关口咽癌的效果(PATH研究)

2025-10-010
PRE
Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure

鼻窦癌的质子治疗: 临床结果和失败模式

2025-10-010
PRE
The Use of Proton Radiation in the Management of Adenoid Cystic CarcinomaProton Therapy for Head and Neck Adenoid Cystic Carcinoma (ACC)

腺样囊性癌管理中质子辐射的应用 头颈部腺样囊性癌(ACC)的质子治疗

2025-10-010
OAAI
Osteoradionecrosis as a complication following post-operative intensity-modulated radiation therapy or proton therapy for oral cavity cancer

口腔癌术后调强放射治疗或质子治疗后的放射性骨坏死并发症

2025-08-080
PRE
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like Carcinoma
2025-03-010
PRE
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWERCSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6
2025-01-013
PRE
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
2023-09-2925
OA
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
2023-08-2416
OA
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
2023-06-013
OAAI